The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
N-Acetyl Aspartate: A Marker for Neuronal Loss or Mitochondrial Dysfunction
Abstract
Review Articles| October 30 1998 N-Acetyl Aspartate: A Marker for Neuronal Loss or Mitochondrial Dysfunction Subject Area: Further Areas , Neurology and Neuroscience , Women's and Children's Health J.B. Clark J.B. Clark Department of Neurochemistry,Institute of Neurology,University College London, London, UK Search for other works by this author on: This Site PubMed Google Scholar Dev Neurosci (1998) 20 (4-5): 271–276. https://doi.org/10.1159/000017321 Article history Published Online: October 30 1998 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation J.B. Clark; N-Acetyl Aspartate: A Marker for Neuronal Loss or Mitochondrial Dysfunction. Dev Neurosci 1 October 1998; 20 (4-5): 271–276. https://doi.org/10.1159/000017321 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsDevelopmental Neuroscience Search Advanced Search Article PDF first page preview Close Modal Keywords: N-acetyl aspartate, Mitochondria, Energy metabolism, MRS/MRI, Neurodegradation, Neuronal loss 1998Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. You do not currently have access to this content.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types
Urenjak, J., Williams, Sr., Gadian, D., & Noble, M. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-03-00981.1993 · Cited by 995
Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions
Davie, C. A., Hawkins, C. P., Barker, G. J., Brennan, A., Tofts, P. S., Miller, D. H., & McDonald, W. I. (1994) · Brain · doi:10.1093/brain/117.1.49 · Cited by 534
Urenjak, J., Williams, S. R., Gadian, D. G., & Noble, M. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08875.x · Cited by 503
Reversible decreases in N‐acetylaspartate after acute brain injury
Stefano, N. D., Matthews, P. M., & Arnold, D. L. (1995) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910340511 · Cited by 438
Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo.
Bates, T. E., Strangward, M., Keelan, J., Davey, G. P., Munro, P., & Clark, J. B. (1996) · PubMed · Cited by 422
Self-citationAspartoacylase deficiency and N‐acetylaspartic aciduria in patients with canavan disease
Matalon, R., Michals, K., Sebesta, D., Deanching, M., Gashkoff, P., Casanova, J., Optiz, J. M., & Reynolds, J. F. (1988) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320290234 · Cited by 404
Koller, K. J., Zaczek, R., & Coyle, J. T. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb12854.x · Cited by 343
N-ACETYL-l-ASPARTIC ACID IN BRAIN
Tallan, H. H., Moore, S., & Stein, W. H. (1956) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)65789-8 · Cited by 325
Comparative Neuropathology of Chronic Experimental Allergic Encephalomyelitis and Multiple Sclerosis
Lassmann, H. (1983) · Schriftenreihe Neurologie / Neurology Series · doi:10.1007/978-3-642-45558-2 · Cited by 296
STUDIES ON THE DISTRIBUTION OF N-ACETYL-l-ASPARTIC ACID IN BRAIN
Tallan, H. H. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)65008-2 · Cited by 294
Cited by
N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology
Moffett, J. R., Ross, B., Arun, P., Madhavarao, C. N., & Namboodiri, A. M. A. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.12.003 · Cited by 1,405
Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis
Rossignol, D. A., & Frye, R. E. (2012) · Molecular Psychiatry · doi:10.1038/mp.2010.136 · Cited by 907
Prefrontal neurons and the genetics of schizophrenia
Weinberger, D. R., Egan, M. F., Bertolino, A., Callicott, J. H., Mattay, V. S., Lipska, B. K., Berman, K. F., & Goldberg, T. E. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01252-5 · Cited by 741
Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences
Bjartmar, C., & Trapp, B. D. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200106000-00003 · Cited by 479
Stork, C., & Renshaw, P. F. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001711 · Cited by 477
Brain Metabolic Alterations in Medication-Free Patients With BipolarDisorder
Dager, S. R., Friedman, S. D., Parow, A., Demopulos, C., Stoll, A. L., Lyoo, I. K., Dunner, D. L., & Renshaw, P. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.5.450 · Cited by 453
Mitochondrial Dysfunction and Psychiatric Disorders
Rezin, G. T., Amboni, G., Zugno, A. I., Quevedo, J., & Streck, E. L. (2009) · Neurochemical Research · doi:10.1007/s11064-008-9865-8 · Cited by 442
Neocortical neuronal, synaptic, and glial loss in multiple sclerosis
Wegner, C., Esiri, M. M., Chance, S. A., Palace, J., & Matthews, P. M. (2006) · Neurology · doi:10.1212/01.wnl.0000237551.26858.39 · Cited by 441
Neurobiology and consequences of social isolation stress in animal model—A comprehensive review
Mumtaz, F., Khan, M. I., Zubair, M., & Dehpour, A. R. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.086 · Cited by 369
Rossignol, D. A., & Frye, R. E. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00150 · Cited by 369
The in-depth evaluation of suspected mitochondrial disease
Haas, R. H., Parikh, S., Falk, M. J., Saneto, R. P., Wolf, N. I., Darin, N., Wong, L.-J., Cohen, B. H., & Naviaux, R. K. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.11.018 · Cited by 365
Mitochondrial involvement in psychiatric disorders
Shao, L., Martin, M. V., Watson, S. J., Schatzberg, A., Akil, H., Myers, R. M., Jones, E. G., Bunney, W. E., & Vawter, M. P. (2008) · Annals of Medicine · doi:10.1080/07853890801923753 · Cited by 305
Clark, V. P., Coffman, B. A., Trumbo, M. C., & Gasparovic, C. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.05.244 · Cited by 284
MR Spectroscopic Studies of the Brain in Psychiatric Disorders
Maddock, R. J., & Buonocore, M. H. (2011) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2011_197 · Cited by 262
Review: Mitochondria and disease progression in multiple sclerosis
Mahad, D., Lassmann, H., & Turnbull, D. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00987.x · Cited by 193
Updates on mouse models of Alzheimer’s disease
Zhong, M. Z., Peng, T., Duarte, M. L., Wang, M., & Cai, D. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00712-0 · Cited by 189
“NAA is a metabolite considered to reflect neuronal mitochondrial function [36, 37].”
BackgroundMitochondria and Huntington's Disease Pathogenesis: Insight from Genetic and Chemical Models
Browne, S. E. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.018 · Cited by 176
Silaidos, C., Pilatus, U., Grewal, R., Matura, S., Lienerth, B., Pantel, J., & Eckert, G. P. (2018) · Biology of Sex Differences · doi:10.1186/s13293-018-0193-7 · Cited by 137
Zhu, X., & Chen, W. (2001) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1267 · Cited by 92
“It has been shown that NAA is an in vivo marker of neuronal density (20).”
BackgroundGonzales, M. M., Tarumi, T., Kaur, S., Nualnim, N., Fallow, B. A., Pyron, M., Tanaka, H., & Haley, A. P. (2013) · Brain Topography · doi:10.1007/s10548-012-0248-8 · Cited by 52
“NAA is synthesized from acetylcoA and aspartate within the mitochondria and is therefore, directly related to mitochondrial viability (Clark 1998).”
BackgroundKnapman, A., Kaltwasser, S. F., Martins‐de‐Souza, D., Holsboer, F., Landgraf, R., Turck, C. W., Czisch, M., & Touma, C. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07968.x · Cited by 44
Saccaro, L. F., Tassone, M., Tozzi, F., & Rutigliano, G. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.03.150 · Cited by 42
Aspartoacylase supports oxidative energy metabolism during myelination
Francis, J. S., Strande, L., Markov, V., & Leone, P. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.66 · Cited by 41
Hall, H., Cuellar-Baena, S., Dahlberg, C., in’t Zandt, R., Denisov, V., & Kirik, D. (2011) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2011_166 · Cited by 17
Endogenous aspartoacylase expression is responsive to glutamatergic activity in vitro and in vivo
Francis, J. S., Strande, L., Pu, A., & Leone, P. (2011) · Glia · doi:10.1002/glia.21187 · Cited by 12
Martens, L., Herrmann, L., Colic, L., Li, M., Richter, A., Behnisch, G., Stork, O., Seidenbecher, C., Schott, B. H., & Walter, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-86220-3 · Cited by 12
Brain neurochemical and hemodynamic findings in the NY1DD mouse model of mild sickle cell disease
Cui, M., Suzuka, S. M., Branch, N. A., Ambadipudi, K., Thangaswamy, S., Acharya, S. A., Billett, H. H., & Branch, C. A. (2017) · NMR in Biomedicine · doi:10.1002/nbm.3692 · Cited by 11
Metadata
- Authors
- Clark, J. B.
- Venue
- Developmental Neuroscience
- Publisher
- S. Karger AG
- Published
- 1998
- Volume
- 20
- Issue
- 4-5
- Pages
- 271-276
- ISSN
- 0378-5866 (ISSN-L)
- 1421-9859
- OpenAlex
- W2057327829
- Cited by
- 394
- References
- 28
- FWCI
- 10.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.